Hamlet Pharma
Elisabeth Parker appointed as Business development expert in Hamlet BioPharma and joins the team on March 3rd
REG
Dr Parker received a PhD in 1998 from the Medical Faculty, Lund University, Sweden. More recently, she has served as Director of Business Development at the Immunotherapy company Macrophage Pharma, Business development executive at the development and commercialization arm of Cancer Research UK (CRUK) and Non-Executive Board Director of Azeria Ltd and Arquer diagnostics Ltd.
This recruitment strengthens the business development process of Hamlet BioPharma and adds high profile pharma competence and active international networks, says Catharina Svanborg, CEO of Hamlet BioPharma.
For more information, please contact:
Catharina Svanborg, CEO.
Phone: +46 709 42 65 49
E-mail: catharina.svanborg@hamletbiopharm
| Datum | 2025-02-19, kl 16:00 |
| Källa | Cision |
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!